Rumenil 34 mg/ml Oral Suspension for Cattle
Rumenil 34 mg/ml Oral Suspension for Cattle
Authorised
- Oxyclozanide
Product identification
Medicine name:
Rumenil 34 mg/ml oral suspension for cattle
Rumenil 34 mg/ml Oral Suspension for Cattle
Active substance:
- Oxyclozanide
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxyclozanide34.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal13day
-
Milk108hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AG05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
United Kingdom (Northern Ireland)
Package description:
- 1L: White High Density Polyethylene HDPE flexi containers with a Polypropylene cap and a PVDC sealThe product can be marketed with or without an outer carton.
- 2.5L: White High Density Polyethylene HDPE flexi containers with a Polypropylene cap and a PVDC sealThe product can be marketed with or without an outer carton.
- 5L: White High Density Polyethylene HDPE flexi containers with a Polypropylene cap and a PVDC sealThe product can be marketed with or without an outer carton.
- 10 L: High Density Polyethylene (HDPE) container with a HDPE cap and an aluminium foil seal.The product can be marketed with or without an outer carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- The Veterinary Medicines Directorate
Authorisation number:
- Vm 08749/4077
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0369/001
Concerned member states:
-
Bulgaria
-
Hungary
-
Italy
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet